Literature DB >> 12151336

p21-activated kinase 1 interacts with and phosphorylates histone H3 in breast cancer cells.

Feng Li1, Liana Adam, Ratna K Vadlamudi, Hongyi Zhou, Subrata Sen, Jonathan Chernoff, Mahitosh Mandal, Rakesh Kumar.   

Abstract

Stimulation of p21-activated kinase-1 (Pak1) signaling promotes motility, invasiveness, anchorage-independent growth and abnormal mitotic assembly in human breast cancer cells. Here, we provide new evidence that, before the onset of mitosis, activated Pak1 is specifically localized with the chromosomes during prophase and on the centrosomes in metaphase and moves to the contraction ring during cytokinesis. To identify mitosis-specific substrates of Pak1, we screened a synchronized G2-M expression library by using a glutathione transferase Pak1 solid-phase-based kinase reaction. This analysis identified histone H3 as a substrate of Pak1 both in vitro and in vivo, and it specifically interacted with Pak1 but not Pak2 or Pak3. Site-directed mutagenesis indicated that Pak1 phosphorylates histone H3 on Ser10. Expressions of the wild-type, or catalytically active, Pak1 caused it to appear at the poles corresponding to mitotic centrosomes in a variety of mammalian cells. Together, these results suggest for the first time that Pak1 interacts with and phosphorylates histone H3 and may thus influence the Pak1-histone H3 pathway, which in turn may influence mitotic events in breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12151336      PMCID: PMC1084211          DOI: 10.1093/embo-reports/kvf157

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  19 in total

1.  Core histone N-termini play an essential role in mitotic chromosome condensation.

Authors:  A E de la Barre; V Gerson; S Gout; M Creaven; C D Allis; S Dimitrov
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

Review 2.  Signaling to chromatin through histone modifications.

Authors:  P Cheung; C D Allis; P Sassone-Corsi
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 3.  Translating the histone code.

Authors:  T Jenuwein; C D Allis
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

Review 4.  Chromosomal passengers and the (aurora) ABCs of mitosis.

Authors:  R R Adams; M Carmena; W C Earnshaw
Journal:  Trends Cell Biol       Date:  2001-02       Impact factor: 20.808

5.  Chromosomal passengers: toward an integrated view of mitosis.

Authors:  W C Earnshaw; R L Bernat
Journal:  Chromosoma       Date:  1991-03       Impact factor: 4.316

6.  Localization of cytoplasmic dynein to mitotic spindles and kinetochores.

Authors:  E R Steuer; L Wordeman; T A Schroer; M P Sheetz
Journal:  Nature       Date:  1990-05-17       Impact factor: 49.962

7.  Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor.

Authors:  A Mazumdar; R A Wang; S K Mishra; L Adam; R Bagheri-Yarmand; M Mandal; R K Vadlamudi; R Kumar
Journal:  Nat Cell Biol       Date:  2001-01       Impact factor: 28.824

8.  Components of the human spindle checkpoint control mechanism localize specifically to the active centromere on dicentric chromosomes.

Authors:  R Saffery; D V Irvine; B Griffiths; P Kalitsis; K H Choo
Journal:  Hum Genet       Date:  2000-10       Impact factor: 4.132

9.  Differential regulation of CENP-A and histone H3 phosphorylation in G2/M.

Authors:  S G Zeitlin; C M Barber; C D Allis; K F Sullivan; K Sullivan
Journal:  J Cell Sci       Date:  2001-02       Impact factor: 5.285

10.  Temporal and spatial distribution of activated Pak1 in fibroblasts.

Authors:  M A Sells; A Pfaff; J Chernoff
Journal:  J Cell Biol       Date:  2000-12-25       Impact factor: 10.539

View more
  48 in total

Review 1.  PAK1 as a therapeutic target.

Authors:  Julia V Kichina; Anna Goc; Belal Al-Husein; Payaningal R Somanath; Eugene S Kandel
Journal:  Expert Opin Ther Targets       Date:  2010-07       Impact factor: 6.902

Review 2.  Molecular pathways: targeting p21-activated kinase 1 signaling in cancer--opportunities, challenges, and limitations.

Authors:  Jeyanthy Eswaran; Da-Qiang Li; Anil Shah; Rakesh Kumar
Journal:  Clin Cancer Res       Date:  2012-05-17       Impact factor: 12.531

3.  Inactivation of Rho GTPases with Clostridium difficile toxin B impairs centrosomal activation of Aurora-A in G2/M transition of HeLa cells.

Authors:  Yoshikazu Ando; Shingo Yasuda; Fabian Oceguera-Yanez; Shuh Narumiya
Journal:  Mol Biol Cell       Date:  2007-07-18       Impact factor: 4.138

Review 4.  p21-Activated Kinases in Thyroid Cancer.

Authors:  Luis Bautista; Christina M Knippler; Matthew D Ringel
Journal:  Endocrinology       Date:  2020-08-01       Impact factor: 4.736

Review 5.  Signaling coupled epigenomic regulation of gene expression.

Authors:  R Kumar; S Deivendran; T R Santhoshkumar; M R Pillai
Journal:  Oncogene       Date:  2017-06-26       Impact factor: 9.867

6.  Signaling-dependent phosphorylation of mitotic centromere-associated kinesin regulates microtubule depolymerization and its centrosomal localization.

Authors:  Suresh B Pakala; Vasudha S Nair; Sirigiri DivijendraNatha Reddy; Rakesh Kumar
Journal:  J Biol Chem       Date:  2012-10-10       Impact factor: 5.157

Review 7.  Structure, biochemistry, and biology of PAK kinases.

Authors:  Rakesh Kumar; Rahul Sanawar; Xiaodong Li; Feng Li
Journal:  Gene       Date:  2016-12-19       Impact factor: 3.688

8.  p21-activated kinase-1 signaling regulates transcription of tissue factor and tissue factor pathway inhibitor.

Authors:  Beatriz Sánchez-Solana; Mona Motwani; Da-Qiang Li; Jeyanthy Eswaran; Rakesh Kumar
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

Review 9.  Integrins as regulators of the mitotic machinery.

Authors:  Susan E LaFlamme; Bethsaida Nieves; Diane Colello; Carlos G Reverte
Journal:  Curr Opin Cell Biol       Date:  2008-07-25       Impact factor: 8.382

Review 10.  PAK signaling in oncogenesis.

Authors:  P R Molli; D Q Li; B W Murray; S K Rayala; R Kumar
Journal:  Oncogene       Date:  2009-05-25       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.